(Q48036778)

7 February 2018

title

Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum (English)

1 reference

7 February 2018

main subject

Plasmodium falciparum

0 references

0 references

1 reference

Hussein Z

1

1 reference

7 February 2018

Eaves J

series ordinal

2

1 reference

7 February 2018

Hutchinson DB

series ordinal

3

1 reference

7 February 2018

Canfield CJ

series ordinal

4

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

7 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

7 February 2018

volume

61

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

page(s)

518-530

1 reference

7 February 2018

Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Examination of some factors responsible for a food-induced increase in absorption of atovaquone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Oral Atovaquone Compared with Intravenous Pentamidine for Pneumocystis carinii Pneumonia in Patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Malaria--resurgence, resistance, and research. (First of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Clinical experience with atovaquone: a new drug for treating Pneumocystis carinii pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Atovaquone for Pneumocystis carinii pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

The effects of antimalarials on the Plasmodium falciparum dihydroorotate dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Multiresistant falciparum malaria cured using atovaquone and proguanil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

inferred from DOI database lookup

7 January 2021

based on heuristic

High-performance liquid chromatographic assay for the measurement of atovaquone in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

Differences in plasma binding of drugs between Caucasians and Chinese subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990132-6

10.1016/S0009-9236(97)90132-6

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018